Surgery Partners (1SP) Price & Analysis

1 Followers

1SP Stock Chart & Stats

€13.80

€0.60(4.55%)

At close: Jul 24 4:00 PM EDT

€13.80

€0.60(4.55%)

Day’s Range― - ―

52-Week Range€9.80 - €20.40

Previous CloseN/A

Volume360.00

Average Volume (3M)12.00

Market Cap

€1.80B

Enterprise Value€7.17K

Total Cash (Recent Filing)€182.30M

Total Debt (Recent Filing)€4.03B

Price to Earnings (P/E)―

Beta0.99

Next Earnings

Aug 10, 2026

EPS Estimate

0.05

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.59

Shares Outstanding130,788,160

10 Day Avg. Volume36

30 Day Avg. Volume12

Financial Highlights & Ratios

PEG Ratio0.47

Price to Book (P/B)1.15

Price to Sales (P/S)0.59

P/FCF Ratio10.05

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€15.13

Price Target Upside9.64% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering7

EPS Forecast (FY)0.38

Revenue Forecast (FY)€2.98B

Bulls Say, Bears Say

Bulls Say

Cash Flow GenerationConsistent positive operating and free cash flow provide durable internal funding for maintenance capex, organic growth and debt service. Over 2–6 months this supports gradual deleveraging, targeted M&A and operational investment without sole reliance on external financing.

Steady Revenue GrowthSurgery Partners’ consistent top‑line growth reflects secular demand for outpatient care, same‑facility expansion and specialty mix improvements (eg, joint growth). Durable revenue momentum underpins long‑term utilization gains and supports margin recovery initiatives.

Portfolio Optimization (Idaho Falls Sale)The announced divestiture materially simplifies the portfolio and should deliver substantial cash proceeds. This structural move enables strategic focus on ASCs, funds deleveraging or targeted M&A, and reduces complexity in hospital operations over the medium term.

Bears Say

Elevated LeverageHigh absolute debt and rising leverage constrain financial flexibility and increase interest sensitivity to rate changes. Even with stable cash flow, elevated debt ratios raise refinancing and covenant risk and limit ability to pursue larger strategic investments without visible deleveraging.

Persistent Net LossesDespite positive EBITDA, recurring GAAP losses and negative ROE reduce retained earnings and long‑term capital return potential. Continued net losses limit capacity to rebuild equity, restrain discretionary investment and prolong reliance on external or one‑time proceeds for balance‑sheet repair.

M&A Execution & Partner RelianceSlow M&A deployment and dependence on physician partnerships create execution risk for growth and scale. If the company cannot consistently close accretive deals or recruit/retain physicians, organic expansion and margin leverage from strategic assets may underdeliver for multiple quarters.

Surgery Partners News

Surgery Partners to sell Mountain View, Idaho Falls hospitals interest for $1.5B

Surgery Partners (SGRY) announced it, along with its existing partner Intermountain Health, has placed into escrow signature pages...

9d ago

SGRY

Surgery Partners Announces Idaho Falls Hospital Divestiture Agreement

Surgery Partners ( ($SGRY) ) just unveiled an announcement. On July 21, 2026, Surgery Partners and Intermountain Health...

9d ago

SGRY

Surgery Partners Shareholders Reaffirm Board, Pay and Auditor

Surgery Partners ( ($SGRY) ) has issued an update. On June 5, 2026, Surgery Partners held its Annual...

2M ago

SGRY

Surgery Partners price target raised to $17 from $15 at Jefferies

Jefferies raised the firm’s price target on Surgery Partners (SGRY) to $17 from $15 and keeps a Buy...

3M ago

SGRY

Surgery Partners Balances Growth Ambitions With Rising Headwinds

Surgery Partners Inc. (($SGRY)) has held its Q1 earnings call. Read on for the main highlights of the...

3M ago

SGRY

Midday Fly By: Palantir reports ‘beat and raise,’ Coinbase to cut staff

The major averages were broadly higher near noon as oil pulls back, though the ceasefire between the U.S....

3M ago

BRC

Surgery Partners reports Q1 adjusted EPS (3c), consensus (14c)

Reports Q1 revenue $810.9M, consensus $797.93M. Eric Evans, Chief Executive Officer, stated, “We are encouraged by our solid...

3M ago

SGRY

Surgery Partners backs FY26 revenue view $3.35B-$3.45B, consensus $3.41B

Backs FY26 adjusted EBITDA view at least $530M. The company said, “The Company reaffirmed its outlook for 2026...

3M ago

SGRY

Surgery Partners Inc. (SGRY) Q1 Earnings Cheat Sheet

Surgery Partners Inc. (SGRY) is scheduled to report 1st quarter earnings on 05/05/2026, before the market opens. Regarding...

3M ago

SGRY

Surgery Partners price target lowered to $15 from $16.25 at Jefferies

Jefferies lowered the firm’s price target on Surgery Partners (SGRY) to $15 from $16.25 and keeps a Buy...

3M ago

SGRY

Ortelius says ‘it’s time for substantial change’ at Surgery Partners

Ortelius Advisors issued an open letter to stockholders of Surgery Partners (SGRY), which read, in part, “Ortelius Advisors...

5M ago

SGRY

Surgery Partners price target lowered to $20 from $28 at TD Cowen

TD Cowen lowered the firm’s price target on Surgery Partners (SGRY) to $20 from $28 and keeps a...

5M ago

SGRY

Surgery Partners price target lowered to $17 from $19 at Mizuho

Mizuho analyst Ann Hynes lowered the firm’s price target on Surgery Partners (SGRY) to $17 from $19 and...

5M ago

SGRY

Surgery Partners price target lowered to $21 from $29 at UBS

UBS lowered the firm’s price target on Surgery Partners (SGRY) to $21 from $29 and keeps a Buy...

5M ago

SGRY

1SP FAQ

What was Surgery Partners Inc’s price range in the past 12 months?

Surgery Partners Inc lowest stock price was €9.80 and its highest was €20.40 in the past 12 months.

What is Surgery Partners Inc’s market cap?

Surgery Partners Inc’s market cap is €1.80B.

When is Surgery Partners Inc’s upcoming earnings report date?

Surgery Partners Inc’s upcoming earnings report date is Aug 10, 2026 which is in 8 days.

How were Surgery Partners Inc’s earnings last quarter?

Surgery Partners Inc released its earnings results on May 05, 2026. The company reported -€0.026 earnings per share for the quarter, beating the consensus estimate of -€0.107 by €0.081.

Is Surgery Partners Inc overvalued?

According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Surgery Partners Inc pay dividends?

Surgery Partners Inc does not currently pay dividends.

What is Surgery Partners Inc’s EPS estimate?

Surgery Partners Inc’s EPS estimate is 0.05.

How many shares outstanding does Surgery Partners Inc have?

Surgery Partners Inc has 130,788,160 shares outstanding.

What happened to Surgery Partners Inc’s price movement after its last earnings report?

Surgery Partners Inc reported an EPS of -€0.026 in its last earnings report, beating expectations of -€0.107. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Surgery Partners Inc?

Currently, no hedge funds are holding shares in DE:1SP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Surgery Partners Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

1.17%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Surgery Partners Inc

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

Surgery Partners (1SP) Earnings & Revenues

Historic Earnings Reports

1SP Company Deck

1SP Earnings Call

Q1 2026

0:00 / 0:00

Earnings Call Sentiment|Neutral

Neutral — The call conveyed cautious optimism: the company reported solid revenue and EBITDA in line with expectations, strong MSK/robotics momentum, physician recruiting progress and reiterated full‑year guidance, but those positives are counterbalanced by below‑trend case growth, payer mix/provider tax headwinds, rising interest expense and elevated leverage that temper near‑term upside.View all DE:1SP earnings summaries

1SP Stock 12 Month Forecast

Average Price Target

€15.13

▲(9.64% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","20":"€20","11.75":"€11.75","14.5":"€14.5","17.25":"€17.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.3748058,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€17.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.130560050833331,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.16236406,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.16</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,11.75,14.5,17.25,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.7,13.98267736923077,14.265354738461538,14.548032107692308,14.830709476923076,15.113386846153846,15.396064215384616,15.678741584615384,15.961418953846154,16.244096323076924,16.526773692307692,16.80945106153846,17.092128430769232,{"y":17.3748058,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.7,13.810043080833333,13.920086161666665,14.0301292425,14.140172323333331,14.250215404166665,14.360258485,14.470301565833331,14.580344646666665,14.6903877275,14.800430808333331,14.910473889166665,15.020516969999997,{"y":15.130560050833331,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.7,13.581720312307692,13.463440624615384,13.345160936923076,13.226881249230768,13.10860156153846,12.990321873846153,12.872042186153847,12.753762498461539,12.635482810769231,12.517203123076923,12.398923435384615,12.280643747692308,{"y":12.16236406,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.9,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.3,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >